Trial intelligence / Profile preview

Insulin lispro absorption with patch pump versus catheter pump and catheter wear-time

NL-OMON36179Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Mar 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of insulin lispro in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Time to peak serum insulin level and Coefficient of variation of insulin levels. Planned start Mar 2011; status: not yet recruiting.

02

Drugs

insulin lispro
03

Conditions

diabetes mellitus type 1 (T1D)

Beyond the preview

Go deeper on NL-OMON36179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call